Pideka Group (Pideka Group) Debt-to-Revenue : 42.35 (As of Sep. 2021)

View and export this data going back to 2021. Start your Free Trial

What is Pideka Group Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Pideka Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2021 was $1.67 Mil. Pideka Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2021 was $9.00 Mil. Pideka Group's annualized Revenue for the quarter that ended in Sep. 2021 was $0.25 Mil. Pideka Group's annualized Debt-to-Revenue for the quarter that ended in Sep. 2021 was 42.35.

Pideka Group Debt-to-Revenue Historical Data

The historical data trend for Pideka Group's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pideka Group Debt-to-Revenue Chart

Pideka Group Annual Data

Trend

Debt-to-Revenue

Pideka Group Quarterly Data
	Mar20	Jun20	Sep20	Mar21	Jun21	Sep21
Debt-to-Revenue	Get a 7-Day Free Trial			-	-	14.96	12.31	42.35

Competitive Comparison of Pideka Group's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Pideka Group's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pideka Group's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pideka Group's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Pideka Group's Debt-to-Revenue falls into.

Pideka Group Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Pideka Group's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(	+	)	/	N/A
	=	N/A

Pideka Group's annualized Debt-to-Revenue for the quarter that ended in Sep. 2021 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(1.671	+	9.002)	/	0.252
	=	42.35

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2021) Revenue data.

Pideka Group Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pideka Group's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Pideka Group (Pideka Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pideka Group Inc (OTCPK:CIMVF) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 King Street West, 2100 Scotia Plaza, Toronto, ON, CAN, M5H 3C2

Website

https://www.ikanikfarms.com

Pideka Group Inc is multi-national operator with a medical grade indoor cultivation facility and laboratory in Colombia which holds GMP-PHARMA and good agricultural and collection practice certifications, and a retail operation in California.